A Study of KQB368 in People With Solid Tumor Cancer

Full Title

A Phase 1/1b, Open-label, Multicenter, Dose Escalation and Dose Expansion Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of KQB368 in Participants with Advanced Solid Malignancies with KRAS G12S or G12C Mutations

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Rona Yaeger’s office at 646-888-5109.

Protocol
26-212
Phase
Phase I (phase 1)
Investigator
Rona Yaeger
Co-Investigators
Kathryn C. Arbour
Diseases
Colorectal Cancer
Endometrial and other Uterine Cancers › Uterine Cancer
Gynecologic Cancer › Uterine (Endometrial) Cancer
Lung Cancer › Lung Cancer, Non-Small Cell
Solid Tumors
Locations
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau
ClinicalTrials.gov ID
NCT07542704
ClinicalTrials.gov
Visit ClinicalTrials.gov for full clinical trial description